• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.02% Nasdaq Up0.17%

    Theravance Inc. (THRX)

    -NasdaqGS
    11.70 Down 0.08(0.68%) 12:18PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 4,758   135,758   24,512  
    Cost of Revenue -   -   -  
    Gross Profit 4,758   135,758   24,512  
    Operating Expenses
    Research Development125,181  117,898  103,568  
    Selling General and Administrative48,440  30,859  30,681  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (168,863) (12,999) (109,737)
    Income from Continuing Operations
    Total Other Income/Expenses Net7,510  460  415  
    Earnings Before Interest And Taxes(161,353)(12,539)(109,322)
    Interest Expense9,348  6,003  6,022  
    Income Before Tax(170,701)(18,542)(115,344)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(170,701)(18,542)(115,344)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (170,701) (18,542) (115,344)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (170,701) (18,542) (115,344)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.